U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774988) titled 'Individualized Education for Bortezomib-Related Symptom Management in Multiple Myeloma' on Aug. 15.
Brief Summary: This study evaluated an individualized, nurse-delivered education program for managing treatment-related symptoms in patients with newly diagnosed multiple myeloma receiving bortezomib for the first time. A total of 40 patients participated. Twenty patients received two individual education sessions in addition to routine care, while 20 patients in the control group received routine care. The education focused on recognition, prevention, and management of common bortezomib-related symptoms, including peripheral neuropat...